Qube Research & Technologies LTD Takeda Pharmaceutical CO LTD Transaction History

Qube Research & Technologies LTD

$62.3 Billion
Q2 2024

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	SELL	$13.89 - $15.04 $4.44 Million - $4.8 Million	-319,309 Reduced 73.66%	114,209 $1.59 Million
Q4 2023 Feb 13, 2024	BUY	$13.36 - $15.43 $1.96 Million - $2.27 Million	146,813 Added 51.21%	433,518 $6.19 Million
Q3 2023 Nov 13, 2023	SELL	$15.03 - $16.32 $6.69 Million - $7.26 Million	-444,953 Reduced 60.81%	286,705 $4.44 Million
Q2 2023 Aug 14, 2023	BUY	$15.57 - $17.11 $6.15 Million - $6.75 Million	394,761 Added 117.18%	731,658 $11.5 Million
Q1 2023 May 15, 2023	BUY	$15.28 - $16.48 $5.15 Million - $5.55 Million	336,897 New	336,897 $5.55 Million
Q2 2022 Aug 15, 2022	SELL	$13.12 - $15.03 $2.86 Million - $3.28 Million	-218,322 Closed	0 $0
Q1 2022 May 09, 2022	BUY	$13.54 - $15.35 $214,933 - $243,665	15,874 Added 7.84%	218,322 $3.13 Million
Q4 2021 Feb 01, 2022	BUY	$13.17 - $16.4 $97,036 - $120,835	7,368 Added 3.78%	202,448 $2.76 Million
Q3 2021 Nov 12, 2021	BUY	$16.3 - $17.26 $3.18 Million - $3.37 Million	195,080 New	195,080 $3.2 Million
Q2 2021 Aug 13, 2021	SELL	$16.55 - $18.64 $3.12 Million - $3.52 Million	-188,713 Closed	0 $0
Q1 2021 May 14, 2021	SELL	$16.71 - $19.9 $160,382 - $191,000	-9,598 Reduced 4.84%	188,713 $3.45 Million
Q4 2020 Feb 16, 2021	SELL	$15.39 - $18.97 $4.32 Million - $5.32 Million	-280,588 Reduced 58.59%	198,311 $3.61 Million
Q3 2020 Nov 12, 2020	BUY	$17.1 - $19.19 $6.03 Million - $6.76 Million	352,389 Added 278.55%	478,899 $8.54 Million
Q2 2020 Aug 14, 2020	BUY	$14.59 - $19.5 $1.85 Million - $2.47 Million	126,510 New	126,510 $2.27 Million
Q1 2020 May 15, 2020	SELL	$13.02 - $20.31 $1.23 Million - $1.92 Million	-94,412 Closed	0 $0
Q4 2019 Feb 13, 2020	BUY	$16.88 - $20.83 $1.09 Million - $1.34 Million	64,525 Added 215.9%	94,412 $1.86 Million
Q3 2019 Nov 13, 2019	SELL	$16.15 - $17.99 $47,044 - $52,404	-2,913 Reduced 8.88%	29,887 $514,000
Q2 2019 Aug 02, 2019	BUY	$16.58 - $20.49 $543,824 - $672,072	32,800 New	32,800 $581,000
Q1 2019 May 15, 2019	SELL	$16.7 - $21.52 $1.16 Million - $1.49 Million	-69,304 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$15.64 - $21.1 $1.08 Million - $1.46 Million	69,304 New	69,304 $1.17 Million

Others Institutions Holding TAK

# of Institutions

320

Shares Held

70.4M

Call Options Held

939K

Put Options Held

233K

Capital Research Global Investors Los Angeles, CA

13.1M
Shares

$182 Million
0.04% of portfolio
Mondrian Investment Partners LTD London, X0

7.74M
Shares

$107 Million
1.74% of portfolio
Morgan Stanley New York, NY

4.99M
Shares

$69.1 Million
0.01% of portfolio
Israel Englander Millennium Management LLC | New York, Ny

4.35M
Shares

$60.2 Million
0.03% of portfolio
Goldman Sachs Group Inc New York, NY

3.72M
Shares

$51.5 Million
0.01% of portfolio

View Full List

About TAKEDA PHARMACEUTICAL CO LTD

Ticker TAK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 3,109,050,112
Market Cap $43.1B
Description
Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan, the United States, Europe, Canada, Latin America, Russia, rest of Asia, and internationally. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma derived t...

More about TAK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Qube Research & Technologies LTD, based on Form 13F filings with the SEC.

News

Stay updated on Qube Research & Technologies LTD with notifications on news.

Account